REQUEST A DEMO
Total
USD $0.00
Search more companies

+Pharma Ceska Republika S.R.O. (Czech Republic)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: +Pharma Ceska Republika S.R.O. Profile Updated: October 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

+Pharma Ceska Republika S.R.O. is based in Czech Republic. The head office is in Prague. The enterprise operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. The company was established on October 06, 2008. It currently has a total number of 25 - 49 (2023) employees. From the latest financial highlights, +Pharma Ceska Republika S.R.O. reported a net sales revenue increase of 25.56% in 2023. Its’ total assets recorded a growth of 10.43%. The net profit margin of +Pharma Ceska Republika S.R.O. decreased by 7.81% in 2023.

Headquarters
U Pergamenky 1522/2
Prague; The City of Prague; Postal Code: 17000

Contact Details: Purchase the +Pharma Ceska Republika S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the +Pharma Ceska Republika S.R.O. report to view the information.
Outstanding Shares:
Purchase the +Pharma Ceska Republika S.R.O. report to view the information.
Registered Capital:
Purchase the +Pharma Ceska Republika S.R.O. report to view the information.
Incorporation Date:
October 06, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after +Pharma Ceska Republika S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
25.56%
Total operating revenue
25.49%
Operating profit (EBIT)
45.8%
EBITDA
45.23%
Net Profit (Loss) for the Period
-49.5%
Total assets
10.43%
Total equity
14.77%
Operating Profit Margin (ROS)
2.66%
Net Profit Margin
-7.81%
Return on Equity (ROE)
11.92%
Quick Ratio
0.05%
Cash Ratio
-0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?